Emma Sierecki

image - Image Emma2 2

Seeing protein-protein interactions in a new way

Emma Sierecki–together with Yann Gambin–is mapping protein interactions to solve mysteries that have so far eluded researchers. Their strategy–combining cell-free protein expression with AlphaScreen and single molecule fluorescence spectroscopy–allows them to rapidly screen a huge number of protein binding partners.

“So much of the bigger picture has been previously missed. Protein networks play a major role in gene regulation and immunity,” says Emma.

By figuring out which proteins bind together, they have identified how 25 subunits come together to form the Mediator–the biggest adapter protein complex that regulates gene transcription.

Protein-Protein interactions

How do cells react to their environment? A cell constantly receives internal and external signals that can be contradictory. One way to integrate this information is the formation of physical protein complexes. Formation of protein complexes allows a finite number of signaling proteins to create an almost infinite number of combinations and to fine-tune the signaling output. Mapping the hierarchical assembly of these complexes is essential to understand their function.

We are particularly interested in protein complex formation in gene regulation and innate immunity.

Protein-protein interaction analysis platform

A novel combination of cell-free protein co-expressions, a nanobead-based binding assay (AlphaScreen) and single-molecule spectroscopy accelerates the measure of direct binding between proteins and determines the stoichiometries of interactions. The workflow to screen protein-protein interactions in vitro is as follows:

For each protein of interest, potential interactors are selected from the literature or from proteomics analyses. The relevant ORFs (Open Reading Frames) are cloned into a series of compatible Gateway vectors to generate fusion proteins bearing a fluorescent tag (GFP or Cherry). The proteins are expressed in a cell-free expression system that possesses the full eukaryotic folding machinery. Pairwise interactions are then tested after coexpression using a nanobead proximity assay (AlphaScreen). AlphaScreen provides rapid access to interaction heat maps as we can routinely analyse more than a hundred pairs a day. The positive hits are further characterized by single-molecule coincidence that provides information on the stoichiometry. The aggregation status is also assessed by single molecule “counting”.

Molecular machines in gene regulation

Gene expression is an exquisitely regulated process. Production of mRNA, mediated by RNA Polymerase II (polII) in association with general transcription factors is one checkpoint in gene regulation. Specific transcription factors binding DNA upstream or downstream of the gene of interest act as activators or repressors of the transcription.  Large “adaptor” protein complexes, such as Mediator, are instrumental in integrating signals from transcription factors and nuclear complexes.

The Mediator complex is a master regulator of eukaryotic transcription. Composed of 25 subunits for a total molecular weight of 1.2 MDa, Mediator is one of the largest and most difficult to study protein machines. Using single molecule techniques we are systematically analysing protein-protein and protein-DNA interactions to reveal the organisation of human Mediator. We are also identifying transcription factor binding sites.

We aim to examine in more detail the tripartite interaction between Mediator, transcription factors and DNA. In particular, we want to study how the interaction network is affected by binding to DNA or to a specific transcription factor in order to predict the potential changes in structure of this complex.

Interactome of transcription factors

During embryogenesis, expression of a specific transcription factors is necessary but not sufficient for cell differentiation; only combinations of transcription factors working in synchronisation lead to the appropriate cell fate.

In light of this, we aim to define the molecular mode of action of SOX18, a transcription factor that governs the specification of lymphatic endothelial cell fate and plays a role in tumour-induced lymphangiogenesis. Specifically, we want to understand how its activity is modulated by specific interacting partners.

A list of protein partners of SOX18 have been identified by RHIME, ChiP-MS and GST pull-down. Using an in vitro protein-protein interaction assay, the interactions between ALL protein pairs are examined to create a comprehensive interactome, including the indirect interactors.

We are also interested in understanding how naturally occurring mutations linked to diseases affect the ability of SOX18 to recruit specific protein partners.

Finally, the interaction network can be used as a new tool for drug discovery. We can discriminate between molecules that disrupt the whole network, partially affect it or selectively break a specific interaction.

Cross-talk in innate immunity

Innate immunity is the first barrier against danger. Immune cells detect and react to dangers that can take multiple forms, signalling has to be fast and elicit the appropriate response. Cross-talk between the different detection pathways is therefore essential. We would like to map the different combinations of receptors/ adaptors/ effectors that are available to get a better understanding of the signalling processes. This would yield a list of biophysically validated interactors. More interestingly, acquisition of data in a matrix approach for all pairs of proteins involved in a specific signalling pathway will provide insight into the network at play and allow identification of effectors that are not actual binders.


Select Publications

Sierecki E, Stevers LM, Giles N, Polinkovsky ME, Moustaqil M, Mureev S, Johnston WA, Dahmer-Heath M, Skalamera D, Gonda TJ, Gabrielli B, Collins BM, Alexandrov K, Gambin Y. Rapid mapping of interactions between Human SNX-BAR proteins measured in vitro by AlphaScreen and single-molecule spectroscopy. (2014). Mol Cell Proteomics. 13(9), 2233-45.

Brooks AJ, Dai W, O'Mara ML, Abankwa D, Chhabra Y, Pelekanos RA, Gardon O, Tunny KA, Blucher KM, Morton CJ, Parker MW, Sierecki E, Gambin Y, Gomez GA, Alexandrov K, Wilson IA, Doxastakis M, Mark AE, Waters MJ. (2014). Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science. 344(6185), 1249783.

Martin S, Papadopulos A, Tomatis VM, Sierecki E, Malintan NT, Gormal RS, Giles N, Johnston WA, Alexandrov K, Gambin Y, Collins BM, Meunier FA. (2014). Increased polyubiquitination and proteasomal degradation of a Munc18-1 disease-linked mutant causes temperature-sensitive defect in exocytosis. Cell Reports. 9(1), 206-18.

Sierecki E, Newton AC.(2014). Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase.Biochemistry. 53(24), 3971-81.

Sierecki E, Giles N, Polinkovsky M, Moustaqil M, Alexandrov K, Gambin Y. (2013). A cell-free approach to accelerate the study of protein-protein interactions in vitro. Interface. 3(5), 20130018. doi: 10.1098/rsfs.2013.0018.

Full list of publications


More Information

In the News